CPRX - Catalyst Pharmaceuticals Inc. (CPRX) CEO Patrick McEnany on Q4 2021 Results - Earnings Call Transcript

Start Time: 08:30 End Time: 09:31 Catalyst Pharmaceuticals, Inc. (CPRX) Q4 2021 Earnings Conference Call March 17, 2022, 08:30 AM ET Company Participants Patrick McEnany - Co-Founder, Chairman, President and CEO Alicia Grande - VP, CFO and Treasurer Steven Miller - COO and Chief Scientific Officer Jeff Del Carmen - Chief Commercial Officer Gary Ingenito - Chief Medical and Regulatory Officer Conference Call Participants Joseph Catanzaro - Piper Sandler Charles Duncan - Cantor Fitzgerald Scott Henry - ROTH Capital Partners Joon Lee - Truist Securities Presentation Operator Greetings, and welcome to the Catalyst Pharmaceuticals Fourth Quarter and Full Year 2021 Results Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]. As a reminder, this conference is being recorded. I would now like to turn the conference over to your host, Ali Grande, Chief Financial Officer for Catalyst Pharmaceuticals.

For further details see:

Catalyst Pharmaceuticals, Inc. (CPRX) CEO Patrick McEnany on Q4 2021 Results - Earnings Call Transcript